Advertisement

Topics

Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma

20:00 EDT 30 Oct 2017 | Mayo Clinic

ROCHESTER, Minn. ? Mayo Clinic announced today that its Rochester campus is one of 16 cancer centers nationally selected to provide chimeric antigen receptor T-cell therapy (CAR T-cell therapy) for adults with?B-cell non-Hodgkin lymphoma?who have not responded to, or have relapsed, after two or more lines of treatment. The therapy, called axicabtagene ciloleucel (Yescarta), is [...]

Original Article: Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma

NEXT ARTICLE

More From BioPortfolio on "Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Hodgkin lymphoma
Hodgkin Lymphoma is a  disorder caused by malignant proliferation of lymphocytes, which contain characteristic mirror-image nuclei (Reed-Sternburg cells). The resulting lymphadenopathy can be limited to a single lymph node region (Stage 1) or spread...